The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A

The coumarins represent a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that were isolated from tropical plants. (+)-Calanolide A, the most potent compound of this class, selects for the T139I resistance mutation in HIV-1 reverse transcriptase (RT). Seven RTs mutated at am...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular pharmacology 2005-09, Vol.68 (3), p.652-659
Hauptverfasser: Auwerx, Joeri, Rodríguez-Barrios, Fátima, Ceccherini-Silberstein, Francesca, San-Félix, Ana, Velázquez, Sonsoles, De Clercq, Erik, Camarasa, María-José, Perno, Carlo-Federico, Gago, Federico, Balzarini, Jan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 659
container_issue 3
container_start_page 652
container_title Molecular pharmacology
container_volume 68
creator Auwerx, Joeri
Rodríguez-Barrios, Fátima
Ceccherini-Silberstein, Francesca
San-Félix, Ana
Velázquez, Sonsoles
De Clercq, Erik
Camarasa, María-José
Perno, Carlo-Federico
Gago, Federico
Balzarini, Jan
description The coumarins represent a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that were isolated from tropical plants. (+)-Calanolide A, the most potent compound of this class, selects for the T139I resistance mutation in HIV-1 reverse transcriptase (RT). Seven RTs mutated at amino acid position 139 (Ala, Lys, Tyr, Asp, Ile, Ser, and Gln) were constructed by site-directed mutagenesis. The mutant T139Q enzyme retained full catalytic activity compared with wild-type RT, whereas the mutant T139I, T139S, and T139A RTs retained only 85 to 50% of the activity. Mutant T139K, T139D, and T139Y RTs had seriously impaired catalytic activities. The mutations in the T139I and T139D RTs were shown to destabilize the RT heterodimer. (+)-Calanolide A lost inhibitory activity (up to 20-fold) against the mutant T139Y, T139Q, T139K, and T139I enzymes. All of the mutant enzymes retained marked susceptibility toward the other NNRTIs, including nevirapine, delavirdine, efavirenz, thiocarboxanilide UC-781, quinoxaline GW867420X, TSAO [[2′,5′-bis- O -( tert -butyldimethylsilyl)-β- d -ribofuranosyl]-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-2″,2″-dioxide)] derivatives, and the nucleoside inhibitor, ddGTP. The fact that the T139I RT 1) proved to be resistant to (+)-calanolide A, 2) represents a catalytically efficient enzyme, and 3) requires only a single transition point mutation (ACA→ATA) in codon 139 seems to explain why mutant T139I RT virus strains, but not virus strains containing other amino acid changes at this position, predominantly emerge in cell cultures under (+)-calanolide A pressure.
doi_str_mv 10.1124/mol.105.012351
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17405258</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17405258</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-e7de38949ae8b159b96817175927056e1e208010050f92a04a4b7d8e959f13ac3</originalsourceid><addsrcrecordid>eNpFkM-L1TAQx4Mo7nP16lFyURTpcyZt2uS4PNRdWBDWKt5CXjvdRtqmm7Qr_e-NvAee5gefGb58GHuNsEcUxafRD3sEuQcUucQnbIdSYAaI-JTtAESZKS1_XbAXMf4GwEIqeM4uUOoSy6rYsVj3xO_8QNx3vO4D5pq7iS9pe72OduI347hOvqXONY6mZuM_XVgjr7eZOPI7eqQQidfBTrEJbl5smr7TFN3iHt2y8cXz9x8_ZAc72MkPriV-9ZI96-wQ6dW5XrIfXz7Xh-vs9tvXm8PVbdbkslgyqlrKlS60JXVMiY-6VFhhJbWoQJaEJEABAkjotLBQ2OJYtYq01B3mtskv2bvT3zn4h5XiYkYXGxpSEvJrNFgVIIVUCdyfwCb4GAN1Zg5utGEzCOafZpM0p16ak-Z08Ob8eT2O1P7Hz14T8PYE9O6-_-MCmbm3YbSNH_z9ZkplclNKkf8FoTiD7Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17405258</pqid></control><display><type>article</type><title>The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Auwerx, Joeri ; Rodríguez-Barrios, Fátima ; Ceccherini-Silberstein, Francesca ; San-Félix, Ana ; Velázquez, Sonsoles ; De Clercq, Erik ; Camarasa, María-José ; Perno, Carlo-Federico ; Gago, Federico ; Balzarini, Jan</creator><creatorcontrib>Auwerx, Joeri ; Rodríguez-Barrios, Fátima ; Ceccherini-Silberstein, Francesca ; San-Félix, Ana ; Velázquez, Sonsoles ; De Clercq, Erik ; Camarasa, María-José ; Perno, Carlo-Federico ; Gago, Federico ; Balzarini, Jan</creatorcontrib><description>The coumarins represent a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that were isolated from tropical plants. (+)-Calanolide A, the most potent compound of this class, selects for the T139I resistance mutation in HIV-1 reverse transcriptase (RT). Seven RTs mutated at amino acid position 139 (Ala, Lys, Tyr, Asp, Ile, Ser, and Gln) were constructed by site-directed mutagenesis. The mutant T139Q enzyme retained full catalytic activity compared with wild-type RT, whereas the mutant T139I, T139S, and T139A RTs retained only 85 to 50% of the activity. Mutant T139K, T139D, and T139Y RTs had seriously impaired catalytic activities. The mutations in the T139I and T139D RTs were shown to destabilize the RT heterodimer. (+)-Calanolide A lost inhibitory activity (up to 20-fold) against the mutant T139Y, T139Q, T139K, and T139I enzymes. All of the mutant enzymes retained marked susceptibility toward the other NNRTIs, including nevirapine, delavirdine, efavirenz, thiocarboxanilide UC-781, quinoxaline GW867420X, TSAO [[2′,5′-bis- O -( tert -butyldimethylsilyl)-β- d -ribofuranosyl]-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-2″,2″-dioxide)] derivatives, and the nucleoside inhibitor, ddGTP. The fact that the T139I RT 1) proved to be resistant to (+)-calanolide A, 2) represents a catalytically efficient enzyme, and 3) requires only a single transition point mutation (ACA→ATA) in codon 139 seems to explain why mutant T139I RT virus strains, but not virus strains containing other amino acid changes at this position, predominantly emerge in cell cultures under (+)-calanolide A pressure.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>DOI: 10.1124/mol.105.012351</identifier><identifier>PMID: 15961674</identifier><language>eng</language><publisher>United States: American Society for Pharmacology and Experimental Therapeutics</publisher><subject>Coumarins - pharmacology ; HIV Reverse Transcriptase - antagonists &amp; inhibitors ; HIV Reverse Transcriptase - chemistry ; HIV Reverse Transcriptase - genetics ; Human immunodeficiency virus 1 ; Kinetics ; Models, Molecular ; Mutagenesis, Site-Directed ; Pyranocoumarins ; Reverse Transcriptase Inhibitors - pharmacology ; Threonine - chemistry ; Threonine - physiology</subject><ispartof>Molecular pharmacology, 2005-09, Vol.68 (3), p.652-659</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-e7de38949ae8b159b96817175927056e1e208010050f92a04a4b7d8e959f13ac3</citedby><cites>FETCH-LOGICAL-c354t-e7de38949ae8b159b96817175927056e1e208010050f92a04a4b7d8e959f13ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15961674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Auwerx, Joeri</creatorcontrib><creatorcontrib>Rodríguez-Barrios, Fátima</creatorcontrib><creatorcontrib>Ceccherini-Silberstein, Francesca</creatorcontrib><creatorcontrib>San-Félix, Ana</creatorcontrib><creatorcontrib>Velázquez, Sonsoles</creatorcontrib><creatorcontrib>De Clercq, Erik</creatorcontrib><creatorcontrib>Camarasa, María-José</creatorcontrib><creatorcontrib>Perno, Carlo-Federico</creatorcontrib><creatorcontrib>Gago, Federico</creatorcontrib><creatorcontrib>Balzarini, Jan</creatorcontrib><title>The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>The coumarins represent a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that were isolated from tropical plants. (+)-Calanolide A, the most potent compound of this class, selects for the T139I resistance mutation in HIV-1 reverse transcriptase (RT). Seven RTs mutated at amino acid position 139 (Ala, Lys, Tyr, Asp, Ile, Ser, and Gln) were constructed by site-directed mutagenesis. The mutant T139Q enzyme retained full catalytic activity compared with wild-type RT, whereas the mutant T139I, T139S, and T139A RTs retained only 85 to 50% of the activity. Mutant T139K, T139D, and T139Y RTs had seriously impaired catalytic activities. The mutations in the T139I and T139D RTs were shown to destabilize the RT heterodimer. (+)-Calanolide A lost inhibitory activity (up to 20-fold) against the mutant T139Y, T139Q, T139K, and T139I enzymes. All of the mutant enzymes retained marked susceptibility toward the other NNRTIs, including nevirapine, delavirdine, efavirenz, thiocarboxanilide UC-781, quinoxaline GW867420X, TSAO [[2′,5′-bis- O -( tert -butyldimethylsilyl)-β- d -ribofuranosyl]-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-2″,2″-dioxide)] derivatives, and the nucleoside inhibitor, ddGTP. The fact that the T139I RT 1) proved to be resistant to (+)-calanolide A, 2) represents a catalytically efficient enzyme, and 3) requires only a single transition point mutation (ACA→ATA) in codon 139 seems to explain why mutant T139I RT virus strains, but not virus strains containing other amino acid changes at this position, predominantly emerge in cell cultures under (+)-calanolide A pressure.</description><subject>Coumarins - pharmacology</subject><subject>HIV Reverse Transcriptase - antagonists &amp; inhibitors</subject><subject>HIV Reverse Transcriptase - chemistry</subject><subject>HIV Reverse Transcriptase - genetics</subject><subject>Human immunodeficiency virus 1</subject><subject>Kinetics</subject><subject>Models, Molecular</subject><subject>Mutagenesis, Site-Directed</subject><subject>Pyranocoumarins</subject><subject>Reverse Transcriptase Inhibitors - pharmacology</subject><subject>Threonine - chemistry</subject><subject>Threonine - physiology</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkM-L1TAQx4Mo7nP16lFyURTpcyZt2uS4PNRdWBDWKt5CXjvdRtqmm7Qr_e-NvAee5gefGb58GHuNsEcUxafRD3sEuQcUucQnbIdSYAaI-JTtAESZKS1_XbAXMf4GwEIqeM4uUOoSy6rYsVj3xO_8QNx3vO4D5pq7iS9pe72OduI347hOvqXONY6mZuM_XVgjr7eZOPI7eqQQidfBTrEJbl5smr7TFN3iHt2y8cXz9x8_ZAc72MkPriV-9ZI96-wQ6dW5XrIfXz7Xh-vs9tvXm8PVbdbkslgyqlrKlS60JXVMiY-6VFhhJbWoQJaEJEABAkjotLBQ2OJYtYq01B3mtskv2bvT3zn4h5XiYkYXGxpSEvJrNFgVIIVUCdyfwCb4GAN1Zg5utGEzCOafZpM0p16ak-Z08Ob8eT2O1P7Hz14T8PYE9O6-_-MCmbm3YbSNH_z9ZkplclNKkf8FoTiD7Q</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Auwerx, Joeri</creator><creator>Rodríguez-Barrios, Fátima</creator><creator>Ceccherini-Silberstein, Francesca</creator><creator>San-Félix, Ana</creator><creator>Velázquez, Sonsoles</creator><creator>De Clercq, Erik</creator><creator>Camarasa, María-José</creator><creator>Perno, Carlo-Federico</creator><creator>Gago, Federico</creator><creator>Balzarini, Jan</creator><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20050901</creationdate><title>The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A</title><author>Auwerx, Joeri ; Rodríguez-Barrios, Fátima ; Ceccherini-Silberstein, Francesca ; San-Félix, Ana ; Velázquez, Sonsoles ; De Clercq, Erik ; Camarasa, María-José ; Perno, Carlo-Federico ; Gago, Federico ; Balzarini, Jan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-e7de38949ae8b159b96817175927056e1e208010050f92a04a4b7d8e959f13ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Coumarins - pharmacology</topic><topic>HIV Reverse Transcriptase - antagonists &amp; inhibitors</topic><topic>HIV Reverse Transcriptase - chemistry</topic><topic>HIV Reverse Transcriptase - genetics</topic><topic>Human immunodeficiency virus 1</topic><topic>Kinetics</topic><topic>Models, Molecular</topic><topic>Mutagenesis, Site-Directed</topic><topic>Pyranocoumarins</topic><topic>Reverse Transcriptase Inhibitors - pharmacology</topic><topic>Threonine - chemistry</topic><topic>Threonine - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Auwerx, Joeri</creatorcontrib><creatorcontrib>Rodríguez-Barrios, Fátima</creatorcontrib><creatorcontrib>Ceccherini-Silberstein, Francesca</creatorcontrib><creatorcontrib>San-Félix, Ana</creatorcontrib><creatorcontrib>Velázquez, Sonsoles</creatorcontrib><creatorcontrib>De Clercq, Erik</creatorcontrib><creatorcontrib>Camarasa, María-José</creatorcontrib><creatorcontrib>Perno, Carlo-Federico</creatorcontrib><creatorcontrib>Gago, Federico</creatorcontrib><creatorcontrib>Balzarini, Jan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Auwerx, Joeri</au><au>Rodríguez-Barrios, Fátima</au><au>Ceccherini-Silberstein, Francesca</au><au>San-Félix, Ana</au><au>Velázquez, Sonsoles</au><au>De Clercq, Erik</au><au>Camarasa, María-José</au><au>Perno, Carlo-Federico</au><au>Gago, Federico</au><au>Balzarini, Jan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>68</volume><issue>3</issue><spage>652</spage><epage>659</epage><pages>652-659</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><abstract>The coumarins represent a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that were isolated from tropical plants. (+)-Calanolide A, the most potent compound of this class, selects for the T139I resistance mutation in HIV-1 reverse transcriptase (RT). Seven RTs mutated at amino acid position 139 (Ala, Lys, Tyr, Asp, Ile, Ser, and Gln) were constructed by site-directed mutagenesis. The mutant T139Q enzyme retained full catalytic activity compared with wild-type RT, whereas the mutant T139I, T139S, and T139A RTs retained only 85 to 50% of the activity. Mutant T139K, T139D, and T139Y RTs had seriously impaired catalytic activities. The mutations in the T139I and T139D RTs were shown to destabilize the RT heterodimer. (+)-Calanolide A lost inhibitory activity (up to 20-fold) against the mutant T139Y, T139Q, T139K, and T139I enzymes. All of the mutant enzymes retained marked susceptibility toward the other NNRTIs, including nevirapine, delavirdine, efavirenz, thiocarboxanilide UC-781, quinoxaline GW867420X, TSAO [[2′,5′-bis- O -( tert -butyldimethylsilyl)-β- d -ribofuranosyl]-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-2″,2″-dioxide)] derivatives, and the nucleoside inhibitor, ddGTP. The fact that the T139I RT 1) proved to be resistant to (+)-calanolide A, 2) represents a catalytically efficient enzyme, and 3) requires only a single transition point mutation (ACA→ATA) in codon 139 seems to explain why mutant T139I RT virus strains, but not virus strains containing other amino acid changes at this position, predominantly emerge in cell cultures under (+)-calanolide A pressure.</abstract><cop>United States</cop><pub>American Society for Pharmacology and Experimental Therapeutics</pub><pmid>15961674</pmid><doi>10.1124/mol.105.012351</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-895X
ispartof Molecular pharmacology, 2005-09, Vol.68 (3), p.652-659
issn 0026-895X
1521-0111
language eng
recordid cdi_proquest_miscellaneous_17405258
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry
subjects Coumarins - pharmacology
HIV Reverse Transcriptase - antagonists & inhibitors
HIV Reverse Transcriptase - chemistry
HIV Reverse Transcriptase - genetics
Human immunodeficiency virus 1
Kinetics
Models, Molecular
Mutagenesis, Site-Directed
Pyranocoumarins
Reverse Transcriptase Inhibitors - pharmacology
Threonine - chemistry
Threonine - physiology
title The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T14%3A33%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Thr139%20in%20the%20Human%20Immunodeficiency%20Virus%20Type%201%20Reverse%20Transcriptase%20Sensitivity%20to%20(+)-Calanolide%20A&rft.jtitle=Molecular%20pharmacology&rft.au=Auwerx,%20Joeri&rft.date=2005-09-01&rft.volume=68&rft.issue=3&rft.spage=652&rft.epage=659&rft.pages=652-659&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/10.1124/mol.105.012351&rft_dat=%3Cproquest_cross%3E17405258%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17405258&rft_id=info:pmid/15961674&rfr_iscdi=true